PRTC
PureTech Health plcNASDAQHealthcare$15.50-0.13%ClosedMarket Cap: $377.3M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
0.97
P/S
64.19
EV/EBITDA
2.47
DCF Value
$12.09
FCF Yield
-26.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
338.7%
Operating Margin
-2001.2%
Net Margin
862.2%
ROE
12.8%
ROA
9.2%
ROIC
-20.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2025 | $1.9M | -1245.2% | $-47.9M | $-44.6M | $-1.90 | — |
| Q4 2024 | $4.0M | 1066.7% | $-69.7M | $95.3M | $3.50 | — |
| FY 2024 | $4.8M | 26.0% | $-136.1M | $53.5M | $2.00 | — |
| Q2 2024 | $288.0K | -13416.7% | $-66.4M | $-41.8M | $-1.50 | — |
| Q4 2023 | $178.6K | -940.0% | $-69.5M | $-40.4M | $-0.75 | — |
| FY 2023 | $3.3M | -48.1% | $-146.2M | $-65.7M | $-2.40 | — |
| Q2 2023 | $3.1M | 2.8% | $-76.2M | $-25.0M | $-0.45 | — |
| Q4 2022 | $9.0M | -276.6% | $-101.3M | $-23.1M | $-0.40 | — |
| FY 2022 | $2.1M | -6546.2% | $-197.8M | $-50.4M | $-1.80 | — |
| Q2 2022 | $7.0M | -501.6% | $-101.2M | $-28.3M | $-0.50 | — |
| Q4 2021 | $11.7M | -640.2% | $-83.0M | $15.0M | $0.25 | — |
| FY 2021 | $10.0M | -1007.0% | $-150.3M | $-60.6M | $-2.10 | — |